CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG CLASS
|
|
|
- Regina Robertson
- 5 years ago
- Views:
Transcription
1 ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE ODT TABLETS 15 MG REMERON SOL MIRTAZAPINE ODT TABLETS 30 MG REMERON SOL MIRTAZAPINE ODT TABLETS 45 MG REMERON SOL MIRTAZAPINE TABLET 7.5 MG, 15 MG REMERON MIRTAZAPINE TABLET 30 MG REMERON MIRTAZAPINE TABLET 45 MG REMERON MONOAMINE OXIDASE INHIBITORS (MAOIs) ISOCARBOXAZID TABLETS MARPLAN PHENELZINE SULFATE TABLETS NARDIL SELIGILENE TD PATCH EMSAM X TRANYLCYPROMINE SULFATE TABLETS PARNATE NOREPINEPHRINE and DOPAMINE REUPTAKE INHIBITORS (NDRIs) BUPROPION HCL IR TABLETS 75MG, 100MG WELLBUTRIN BUPROPION HCL ER TABLETS WELLBUTRIN SR BUPROPION HCL ER TABLETS 150MG WELLBUTRIN XL BUPROPION HCL ER TABLETS 300MG WELLBUTRIN XL MAPROTILINE HCL TABLETS LUDIOMIL PA for ages < 6 years SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) CITALOPRAM HBR SOLUTION 900ML 30 CITALOPRAM HBR TABLETS 10 MG, 20 MG CELEXA CITALOPRAM HBR TABLETS 40 MG CELEXA ESCITALOPRAM OXALATE SOLUTION LEXAPRO 600 ML 30 ESCITALOPRAM OXALATE TABLETS 5 MG, 10 MG LEXAPRO ESCITALOPRAM OXALATE TABLETS 20 MG LEXAPRO FLUOXETINE HCL CAPSULES 10 MG, 20 MG PROZAC FLUOXETINE HCL CAPSULES 40 MG PROZAC FLUOXETINE HCL SOLUTION PROZAC 240 ML 30 FLUOXETINE HCL DR CAPSULES PROZAC WEEKLY X FLUVOXAMINE MALEATE ER CAPSULES 100 MG LUVOX CR FLUVOXAMINE MALEATE ER CAPSULES 150 MG LUVOX CR FLUVOXAMINE MALEATE TABLETS 25 MG, 50 MG LUVOX FLUVOXAMINE MALEATE TABLETS 100 MG LUVOX PAROXETINE HCL SUSPENSION PAXIL 900 ML 30 PAROXETINE HCL ER TABLETS 12.5 MG PAXIL CR PAROXETINE HCL ER TABLETS 25 MG PAXIL CR PAROXETINE HCL ER TABLETS 37.5 MG PAXIL CR PAROXETINE HCL TABLETS 10 MG, 20 MG PAXIL PAROXETINE HCL TABLETS 30 MG PAXIL PAROXETINE HCL TABLETS 40 MG PAXIL PAROXETINE MESYLATE TABLETS PEXEVA X SERTRALINE HCL CONCENTRATE ZOLOFT 300 ML 30 SERTRALINE HCL TABLETS 25 MG, 50 MG ZOLOFT SERTRALINE HCL TABLETS 100 MG ZOLOFT VILAZODONE HCL TABLETS VIIBRYD X SEROTONIN-2 ANTAGONIST/REUPTAKE INHIBITORS (SARIs) NEFAZODONE TABLETS TRAZODONE TABLETS SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) DESVENLAFAXINE ER TABLETS 25 MG PRISTIQ Page 1 of 7
2 DESVENLAFAXINE ER TABLETS 50 MG PRISTIQ DESVENLAFAXINE ER TABLETS 100 MG PRISTIQ DULOXETINE CAPSULES 20 MG, 30 MG CYMBALTA DULOXETINE CAPSULES 60 MG CYMBALTA VENLAFAXINE HCL ER CAPSULES 37.5 MG VENLAXINE VENLAFAXINE HCL ER CAPSULES 75 MG EFFEXOR XR VENLAFAXINE HCL ER CAPSULES 150 MG EFFEXOR XR VENLAFAXINE HCL TABLETS (IMMEDIATE RELEASE ONLY) VENLAFAXINE TRICYCLIC ANTIDEPRESSANTS & RELATED NON-SELECTIVE REUPTAKE INHIBITORS AMITRIPTYLINE HCL TABLETS ELAVIL PA for ages < 6 years AMOXAPINE TABLETS ASENDIN PA for ages < 6 years CLOMIPRAMINE HCL TABLETS ANAFRANIL PA for ages < 6 years DESIPRAMINE HCL TABLETS NORPRAMIN PA for ages < 6 years DOXEPIN HCL CAPSULES SINEQUAN PA for ages < 6 years DOXEPIN HCL CONCENTRATE SINEQUAN PA for ages < 6 years IMIPRAMINE HCL CAPSULES TOFRANIL PA for ages < 6 years IMIPRAMINE HCL TABLETS TOFRANIL PA for ages < 6 years NORTRIPTYLINE HCL CAPSULES PAMELOR PA for ages < 6 years NORTRYIPTYLINE HCL SOLUTION PAMELOR PA for ages < 6 years PROTRIPTYLINE HCL TABLETS VIVACTIL PA for ages < 6 years TRIMIPRAMINE MALEATE CAPSULES TRIMIPRAMINE PA for ages < 6 years ANTIPSYCHOTICS ANTIPSYCHOTICS - SECOND GENERATION - ATYPICAL ORAL AGENTS ARIPIPRAZOLE TABLETS ABILIFY PA for ages < 6 years ASENAPINE MALEATE TABLETS SUBLINGUAL SAPHRIS Brand Only PA for ages < 6 years CLOZAPINE ORALLY DISINTEGRATING TABLETS CLOZAPINE ODT PA for ages < 6 years CLOZAPINE TABLETS CLOZAPINE PA for ages < 6 years LURASIDONE TABLETS LATUDA Brand Only PA for ages < 6 years OLANZAPINE ORALLY DISINTEGRATING TABLETS 5MG OLANZAPINE ODT PA for ages < 6 years OLANZAPINE ORALLY DISINTEGRATING TABLETS 10MG OLANZAPINE ODT PA for ages < 6 years OLANZAPINE ORALLY DISINTEGRATING TABLETS 15MG, 20MG OLANZAPINE ODT PA for ages < 6 years OLANZAPINE TABLETS 2.5MG, 5MG OLANZAPINE PA for ages < 6 years OLANZAPINE TABLETS 7.5MG, 10MG OLANZAPINE PA for ages < 6 years OLANZAPINE TABLETS 15MG, 20MG OLANZAPINE PA for ages < 6 years QUETIAPINE FUMARATE TABLETS 25MG, 50MG, 100MG, 150MG, 200MG QUETIAPINE PA for ages < 6 years QUETIAPINE FUMARATE TABLETS 300MG, 400MG QUETIAPINE PA for ages < 6 years RISPERIDONE ORALLY DISINTEGRATING TABLETS 0.25 MG, 0.5MG RISPERIDONE ODT PA for ages < 6 years RISPERIDONE ORALLY DISINTEGRATING TABLETS 1MG, 2MG RISPERIDONE ODT PA for ages < 6 years RISPERIDONE ORALLY DISINTEGRATING TABLETS 3MG, 4MG RISPERIDONE ODT PA for ages < 6 years RISPERIDONE SOLUTION RISPERIDONE PA for ages < 6 years 60ML 30 RISPERIDONE TABLETS 0.25MG, 0.5MG RISPERIDONE PA for ages < 6 years RISPERIDONE TABLETS 1MG, 2MG RISPERIDONE PA for ages < 6 years RISPERIDONE TABLETS 3MG, 4MG RISPERIDONE PA for ages < 6 years ZIPRASIDONE HCL CAPSULES 20MG, 40MG, 60MG ZIPRASIDONE PA for ages < 6 years ZIPRASIDONE HCL CAPSULES 80MG ZIPRASIDONE PA for ages < 6 years ANTIPSYCHOTICS - SECOND GENERATION - ATYPICAL LONG-ACTING INJECTABLES Page 2 of 7
3 ARIPIPRAZOLE LAUROXIL ARISTADA Brand Only PA for ages < 18 years 1 30 ARIPIPRAZOLE SUSPENSION ABILIFY MAINTENA Brand Only PA for ages < 18 years 1 30 PALIPERIDONE PALMITATE SUSPENSION INVEGA SUSTENNA Brand Only PA for ages < 18 years 1 30 PALIPERIDONE PALMITATE SUSPENSION INVEGA TRINZA Brand Only PA for ages < 18 years 1 90 RISPERIDONE MICROSPHERES SUSPENSION RISPERDAL CONSTA Brand Only PA for ages < 6 years 2 28 ANTIPSYCHOTICS - FIRST GENERATION - TYPICAL ORAL AGENTS CHLORPROMAZINE HCL TABLETS THORAZINE PA for ages < 6 years FLUPHENAZINE HCL ELIXIR FLUPHENAZINE PA for ages < 6 years FLUPHENAZINE HCL ORAL CONCENTRATE FLUPHENAZINE PA for ages < 6 years FLUPHENAZINE HCL TABLETS FLUPHENAZINE PA for ages < 6 years HALOPERIDOL LACTATE CONCENTRATE HALDOL PA for ages < 6 years HALOPERIDOL TABLETS HALDOL PA for ages < 6 years LOXAPINE SUCCINATE CAPSULES LOXITANE PA for ages < 6 years PERPHENAZINE TABLETS TRILAFON PA for ages < 6 years PIMOZIDE TABLETS ORAP PA for ages < 6 years THIORIDAZINE HCL TABLETS MELLARIL PA for ages < 6 years THIOTHIXENE CAPSULES NAVANE PA for ages < 6 years TRIFLUOPERAZINE HCL TABLETS STELAZINE PA for ages < 6 years ANTIPSYCHOTICS - FIRST GENERATION - TYPICAL - LONG ACTING INJECTIONS FLUPHENAZINE DECANOATE SOLUTION FLUPHENAZINE DECANOATE PA for ages < 6 years HALOPERIDOL DECANOATE SOLUTION HALDOL DECANOATE PA for ages < 6 years ANTICONVULSANTS CARBAMAZEPINE CHEWABLE TABLETS TEGRETOL CARBAMAZEPINE ER CAPSULES CARBATROL CARBAMAZEPINE ER CAPSULES EQUETRO CARBAMAZEPINE SUSPENSION TEGRETOL CARBAMAZEPINE ER TABLETS TEGRETOL XR CARBAMAZEPINE TABLETS TEGRETOL DIVALPROEX CAPSULES SPRINKLE DPAKOTE SPRINKLES DIVALPROEX DR TABLETS DEPAKOTE DIVALPROEX ER TABLETS DEPAKOTE GABAPENTIN CAPSULES 100MG, 300MG, 400MG NEURONTIN GABAPENTIN ER TABLETS HORIZANT X GABAPENTIN ER TABLETS GRALISE X GABAPENTIN SOLUTION NEURONTIN 1440 ML 30 GABAPENTIN TABLETS 600MG, NEURONTIN GABAPENTIN TABLETS 800MG NEURONTIN LAMOTRIGINE CHEW TABLETS LAMICTAL LAMOTRIGINE ER TABLETS LAMICTAL XR X LAMOTRIGINE ODT TABLETS 25 MG, 50MG LAMICTAL ODT LAMOTRIGINE ODT TABLETS 100 MG LAMICTAL ODT LAMOTRIGINE ODT TABLETS 200 MG LAMICTAL ODT LAMOTRIGINE TABLETS 25 MG LAMICTAL LAMOTRIGINE TABLETS 100 MG LAMICTAL LAMOTRIGINE TABLETS 150 MG, 200 MG LAMICTAL Page 3 of 7
4 OXCARBAZEPINE SOLUTON TRILEPTAL 1050 ML 30 OXCABAZEPINE TABLETS TRILEPTAL TOPIRAMATE CAPSULES TOPAMAX TOPIRAMATE TABLETS TOPAMAX VALPROATE SODIUM CAPSULES DEPAKENE VALPROATE SODIUM SOLUTION DEPAKENE VALPROATE SODIUM SYRUP DEPAKENE ANTIMANIC AGENTS LITHIUM CARBONATE CAPSULES LITHIUM LITHIUM CARBONATE ER TABLETS LITHOBID LITHIUM CITRATE SOLUTION LITHIUM ADHD AGENTS AMPHETAMINES AMPHETAMINE-DEXTROAMPHETAMINE TABLETS 5MG, 7.5MG, 10MG, 12.5MG ADDERALL Brand and Generic PA for ages < 6 years AMPHETAMINE-DEXTROAMPHETAMINE TABLETS 15MG, 20MG, 30MG ADDERALL Brand and Generic PA for ages < 6 years AMPHETAMINE-DEXTROAMPHETAMINE CAPSULES CONTROLLED RELEASE ADDERALL XR Brand Only PA for ages < 6 years DEXTROAMPEHTAMINE SULFATE CAPSULE 24-HOUR PA for ages < 6 years DEXTROAMPHETAMINE SULFATE TABLETS PA for ages < 6 years LISDEXAMFETAMINE ER CAPSULES 10MG, 20MG VYVANSE Brand Only PA for ages < 6 years LISDEXAMFETAMINE ER CAPSULES 30MG VYVANSE Brand Only PA for ages < 6 years LISDEXAMFETAMINE ER CAPSULES 40MG, 50MG, 60MG, 70MG VYVANSE Brand Only PA for ages < 6 years STIMULANTS DEXMETHYLPHENIDATE HCL ER CAPSULE 5MG, 10MG, 15MG, 20MG FOCALIN XR Brand Only PA for ages < 6 years DEXMETHYLPHENIDATE HCL ER CAPSULE 25MG, 30MG, 35MG, 40MG FOXALIN XR Brand Only PA for ages < 6 years DEXMETHYLPHENIDATE HCL TABLETS FOCALIN Brand Only PA for ages < 6 years METHYLPEHNIDATE HCL CHEWABLET TABLET QUILLICHEW Brand Only PA for ages < 6 years METHYLPHENIDATE HCL CHEWABLE TABLETS METHYLIN Brand Only PA for ages < 6 years METHYLPHENIDATE HCL CAPSULE CONTROLLED RELEASE 10MG RITALIN LA Brand Only PA for ages < 6 years METHYLPHENIDATE HCL CAPSULE CONTROLLED RELEASE 20MG METHYLPHENIDATE LA PA for ages < 6 years METHYLPHENIDATE HCL CAPSULE CONTROLLED RELEASE 30MG METHYLPHENIDATE LA PA for ages < 6 years METHYLPHENIDATE HCL CAPSULE CONTROLLED RELEASE 40MG, 60MG METHYLPHENIDATE LA PA for ages < 6 years METHYLPHENIDATE HCL TD PATCH DAYTRANA Brand Only PA for ages < 6 years METHYLPHENIDATE HCL SOLUTION METHYLIN PA for ages < 6 years 900ML 30 METHYLPHENIDATE HCL SUSPENSION QUILLIVANT XR Brand Only PA for ages < 6 years 150 ML 30 METHYLPHENIDATE HCL TABLET CONTROLLED RELEASE 18MG METHYLPEHNIDATE ER PA for ages < 6 years METHYLPHENIDATE HCL TABLET CONTROLLED RELEASE 27MG, 36MG METHYLPEHNIDATE ER PA for ages < 6 years METHYLPHENIDATE HCL TABLET CONTROLLED RELEASE 54MG METHYLPHENIDATE ER PA for ages < 6 years METHYLPHENIDATE HCL TABLETS RITALIN PA for ages < 6 years METHYLPHENIDATE HCL TABLET ER 20MG METHYLPHENIDATE ER PA for ages < 6 years METHYLPHENIDATE HCL TABLET ER 30MG METHYLPHENIDATE ER PA for ages < 6 years METHYLPHENIDATE HCL TABLET ER 40MG METHYLPHENIDATE ER PA for ages < 6 years METHYLPHENIDATE HCL TABLET SUSTAINED RELEASE RITALIN SR PA for ages < 6 years MISCELLANEOUS AGENTS ATOMOXETINE CAPSULES 10MG, 18MG, 25MG, 40MG STRATTERA Brand Only PA for ages < 6 years ATOMOXETINE CAPSULES 60MG, 80MG 100MG STRATTERA Brand Only PA for ages < 6 years CENTRAL ALPHA-AGONISTS CLONIDINE HCL (ADHD) TABLET 12-HOUR KAPVAY Brand Only PA for ages < 6 years CLONIDINE HCL TABLETS CATAPRES PA for ages < 6 years CLONIDINE HCL TD PATCH CATAPRES TTS PA for ages < 6 years 4 30 GUANFACINE HCL (ADHD)TABLET 24-HOUR GUANFACINE HCL ER PA for ages < 6 years GUANFACINE HCL TABLETS TENEX PA for ages < 6 years Page 4 of 7
5 SUBSTANCE ABUSE OPIOID AGONISTS/PARTIAL AGONISTS BUPRENORPHINE HCL SL TABLETS SUBUTEX PA BUPRENORPHINE HCL / NALOXONE SL FILM SUBOXONE FILM Brand Only METHADONE * DOLOPHINE* OPIOID AGONISTS NALOXONE NASAL NARCAN NASAL NALOXONE SYRINGE NALOXONE NALOXONE VIAL NALOXONE NALTREXONE TABLETS REVIA NALTREXONE INJECTION VIVITROL MISCELLANEOUS AGENTS ACAMPROSATE TABLET DELAYED RELEASE CAMPRAL DILSULFIRAM TABLETS ANTABUSE ANXIOLYTICS AND HYPNOTICS BENZODIAZEPINES ALPRAZOLAM CONCENTRATE ALPRAZOLAM INTENSOL PA for > 1 Anxiolytics Fill 60ML 30 ALPRAZOLAM ER TABLET XANAX ER PA for > 1 Anxiolytics Fill ALPRAZOLAM ODT TABLET 0.25MG, 0.5MG, 1MG NIRAVAM PA for > 1 Anxiolytics Fill ALPRAZOLAM ODT TABLET 2MG NIRAVAM PA for > 1 Anxiolytics Fill ALPRAZOLAM TABLET 0.25MG, 0.5MG, 1MG XANAX PA for > 1 Anxiolytics Fill ALPRAZOLAM TABLET 2MG XANAX PA for > 1 Anxiolytics Fill CHLORDIAZEPOXIDE HCL CAPSULES LIBRIUM PA for > 1 Anxiolytics Fill CLONAZEPAM ODT TABLET 0.125MG, 0.25MG, 0.5MG, 1MG KLONOPIN PA for > 1 Anxiolytics Fill CLONAZEPAM ODT TABLET 2MG KLONOPIN PA for > 1 Anxiolytics Fill CLONAZEPAM TABLETS 0.5MG, 1MG KLONOPIN PA for > 1 Anxiolytics Fill CLONAZEPAM TABLETS 2MG KLONOPIN PA for > 1 Anxiolytics Fill CLORAZEPATE DIPOTASSIUM TAB 15 MG PA for > 1 Anxiolytics Fill CLORAZEPATE DIPOTASSIUM TAB 3.75 MG PA for > 1 Anxiolytics Fill CLORAZEPATE DIPOTASSIUM TAB 7.5 MG PA for > 1 Anxiolytics Fill DIAZEPAM CONCENTRATE DIAZEPAM INTENSOL PA for > 1 Anxiolytics Fill 60ML 30 DIAZEPAM SOLUTION DIAZEPAM PA for > 1 Anxiolytics Fill 300ML 30 DIAZEPAM TABLETS VALIUM PA for > 1 Anxiolytics Fill LORAZEPAM CONCENTRATE LORAZEPAM INTENSOL PA for > 1 Anxiolytics Fill 120ML 30 LORAZEPAM TABLETS 0.5MG, 1MG ATIVAN PA for > 1 Anxiolytics Fill LORAZEPAM TABLETS 2MG ATIVAN PA for > 1 Anxiolytics Fill OXAZEPAM CAPSULES OXAZEPAM PA for > 1 Anxiolytics Fill MISCELLANEOUS ANXIOLYTICS BUSPIRONE HCL TABLETS 0.5 MG, 7.5 MG, 10 MG, 15 MG BUSPIRONE HCL BUSPIRONE HCL TABLETS 30 MG BUSPIRONE HCL HYDROXYZINE HCL SYRUP HYDROXYZINE HCL HYDROXYZINE HCL TABLETS HYDROXYZINE HCL HYDROXYZINE PAMOATE CAPSULES VISTARIL MISCELLANEOUS SEDATIVE & HYPNOTICS DOXEPIN HCL TABLETS SILENOR PA for ages < 6 years X ESZOPICLONE TABLETS LUNESTA PA for > 1 Hypnotics Fill ESTAZOLAM TABLETS PA for > 1 Hypnotics Fill FLURAZEPAM HCL CAPSULES DALMANE PA for > 1 Hypnotics Fill MEPROBAMATE TABLETS PA for > 1 Anxiolytics Fill RAMELTEON TABLETS ROZEREM PA for > 1 Hypnotics Fill TEMAZEPAM CAPSULES 15MG, 30MG RESTORIL PA for > 1 Hypnotics Fill Page 5 of 7
6 TRIAZOLAM TABLETS HALCION PA for > 1 Hypnotics Fill ZALEPLON CAPSUELS SONATA PA for > 1 Hypnotics Fill ZOLPIDEM CAPSULES AMBIEN PA for > 1 Hypnotics Fill ZOLPIDEM ER TABLETS AMBIEN CR PA for > 1 Hypnotics Fill X ZOLPIDEM SL TABLETS INTERMEZZO SL PA for > 1 Hypnotics Fill X ZOLPIDEM SL TABLETS EDULAR PA for > 1 Hypnotics Fill X ZOLPIDEM SOLUTION ZOLPIMIST PA for > 1 Hypnotics Fill X ANTIHISTAMINES CYPROHEPTADINE HCL TABLETS DIPHENHYDRAMINE HCL CAPSULES DIPHENHYDRAMINE HCL CHEWABLE TABLETS DIPHENHYDRAMINE HCL ELIXIR DIPHENHYDRAMINE HCL LIQUID DIPHENHYDRAMINE HCL SYRUP DIPHENHYDRAMINE HCL TABLETS HYDROXYZINE HCL TABLETS ATARAX HYDROXYZINE PAMOATE CAPSULES VISTARIL DOPAMINE AGONISTS AMANTADINE HCL CAPSULES SYMMETREL AMANTADINE HCL TABLETS SYMMETREL AUTONOMIC AGONISTS PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS BETHANECHOL CHLORIDE TABLETS URECHOLINE ANTICHOLINERGIC AGENTS BENZTROPINE MESYLATE TABLETS COGENTIN TRIHEXPHENIDYL HCL TABLETS ARTANE CARDIOVASCULAR DRUGS ALPHA-1 ADRENERGIC BLOCKING AGENTS PRAZOSIN HCL CAPSULES MINIPRESS BETA-ADRENERGIC BLOCKING AGENTS NADOLOL TABLETS CORGARD PROPRANOLOL HCL TABLETS INDERAL THRYOID AGENTS LEVOTHYROXINE SODIUM TABLETS LEVOTHROID / SYNTHROID LIOTHYRONINE TABLETS CYTOMEL THRYOID TABLETS ARMOUR THYROID VITAMINS AND OTHER MISCELLANEOUS AGENTS ALPHA-TOCOPHEROL CAPSULES VITAMIN E - CYANOCOBALAMIN TABLETS VITAMIN B12 - FOLIC ACID TABLETS OMEGA 3 FATTY ACID CAPSULES PYRIDOXINE HCL TABLETS VITAMIN B6 - THIAMINE HCL TABLETS VITAMIN B1 - MULTIPLE VITAMIN TABLETS MULTIPLE VITAMIN W/ MINERAL TABLETS SALIVA SUBSTITUTE SPRAY SALIVART DOCUSATE SODIUM CAPSULES COLACE KEY: Drugs listed in Bold/Italic CAPITAL LETTERS indicate the medication is only available as a brand name product. (*) Indicates that medication can only be obtained from an Opioid Treatment Program (OTP) provider. (X) Indicates that the medication requires prior authorization. Page 6 of 7
7 Abbreviations: Cap = capsule HCL = hydrochloride SOLN = solution Chew = chewable IM = intramuscular SR = sustained release Conc = concentrate Inj = injectable Susp = suspension DR = Delayed Release IR = Immediate release Syr = Syrup Elix = Elixir LA = long acting Tab = tablet ER = extended release ODT = orally disintegrating tablet TD = transdermal hbr = hydrobromide SL = sublingual XL = extended release Page 7 of 7
CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only
ACAMPROSATE TABLET DELAYED RELEASE ALPHA-TOCOPHEROL CAPSULES ALPRAZOLAM CONCENTRATE 1 MG/ML ALPRAZOLAM ODT TABLET 0.25MG, 0.5MG, 1MG ALPRAZOLAM ODT TABLET 2MG ALPRAZOLAM SR TABLET 24-HOUR ALPRAZOLAM TABLET
Use Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED
Generic Drugs Are Over Brand Drugs Unless Specified As Brand ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE REMERON 30 30 MIRTAZAPINE REMERON SOLTAB 30 30 ISOCARBOXAZID TABLETS
AHCCCS BEHAVIORAL HEALTH DRUG LIST EFFECTIVE OCTOBER 1, 2016
Generic Drugs Are Preferred Over Brand Name Drugs Unless Specified As Brand Only Federally Reimbursable Drugs Not Listed On The AHCCCS Drug List Are Available Through Prior Authorization Effective Date
Medications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 4/01/2018
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 4/01/2018 Effective April 1, 2014, Mercy Maricopa Integrated Care began operations as the Regional Behavioral Health Authority
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 01/01/2017
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 01/01/2017 Effective April 1, 2014, Mercy Maricopa Integrated Care began operations as the Regional Behavioral Health Authority
Appendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
All formulary medications available in generic form are supplied in generic form. Requests for brand name preparations must get prior authorization.
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 10/01/2018 About the Behavioral Health Drug List The Mercy Care behavioral health drug list includes all of the behavioral health
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 05/01/2015
Title 19/21 GMH/SA & Non-Title 19/21 SMI Behavioral Health Drug List Updated 05/01/2015 Effective April 1, 2014, Mercy Maricopa Integrated Care began operations as the Regional Behavioral Health Authority
U T I L I Z A T I O N E D I T S
I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental
Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
HCA BHS Prescribing Guidelines Committee - Approved Medications 2012
Amitriptyline/Perphenazine Triavil MAJOR TRANQUILIZERS Beneficiaries 10/2, 10/4, 25/2, 25/4, 50/4 Aripiprazole Abilify 2mg, 5mg, 10mg, 15mg, 20mg, 30mg Quantity Limit 31 / mo for Asenapine Saphris 5mg,
Guide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
Dealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
MO Medicaid Foster Care Drugs FY10-FY14
MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri
Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
NorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
Study Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)
2015 Ohana Community Care Services (CCS) Comprehensive referred Drug List (List of Covered Drugs) Ohana Health lan 00 lease read: This document contains information about the drugs we cover in this plan.
PATIENT FACE SHEET PATIENT NAME: PATIENT DOB: PATIENT PHONE #: INSURANCE: MEMBER ID: GROUP NUMBER: PATIENT ADDRESS
1 P a g e PATIENT FACE SHEET PATIENT NAME: PATIENT DOB: PATIENT PHONE #: INSURANCE: MEMBER ID: GROUP NUMBER: PATIENT ADDRESS PRIOR AUTHORIZATION #: (for office use only) INS. CONTACT NAME/ DIRECT NUMBER:
Schedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
May 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator:
May 22, 2013 DAL: DAL 13-11 SUBJECT: Hot Weather Advisory Dear Administrator/Operator: The New York State Department of Health would like to remind you of our expectations regarding the protection of Adult
New Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you.
Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you. In order to make the most of your first appointment, please come at least 30 minutes prior
USF Health Psychiatry Clinic. New Patient Questionnaire Adult
USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days
Psychiatric Intake Form (Please note: if you are not comfortable answering any of the following questions, feel free to leave the space blank)
Past Psychiatric History: What issues or symptoms bring you to this practice? When did these symptoms start? Are the symptoms constant or intermittent? List any previous psychiatric conditions you have
MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)
Pre - PA Allowance Tablets & Suppositories Morphine sulfate tablets Morphine sulfate suppositories Oxymorphone tablets Hydromorphone tablets Hydromorphone suppositories 360 tablets per 90 days OR 360 suppositories
#55 PRESCRIBING AND MONITORING PSYCHI RIC MEDICATIONS
- '_ ADMINISTRA TIVE/FISCAUCLINICAL/PHF POLICY AND PROCEDURES COUNTY OF SANTA BARBARA ALCOHOL, DRUG AND MENTAL HEAL TH SERVICES Section - QUALITY ASSURANCE Effective: 12/1/09 Policy- Director's Approval
ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR
ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if
Duragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist
Pre - PA Allowance Quantity 30 patches every 90 days Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist Age 2 years of age or older Diagnosis Patient must have
HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.
Pre - PA Allowance None Prior authorization is not required if prescribed by an oncologist. Prior-Approval Requirements Age 18 years of age or older Diagnosis Patient must have the following: 1. Pain,
Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None
Pre - PA Allowance None Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist and/or the member has paid pharmacy claims for an oncology medication(s) in the past
Patient History Form
Patient History Form Date: / / NAME: Last First Middle Birthdate: / / Age: Sex: F M Please read the following questions and answer to the best of your ability by placing a check mark in the appropriate
Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?
Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms
Child & Adolescent Patient History Questionnaire
Child & Adolescent Patient History Questionnaire Child s Name: Nickname? Date of Birth: you When? Additional Concerns: Past Psychiatric History Has your child ever seen a psychiatrist? If so, please provide
Psychiatric Evaluation Intake Form
Psychiatric Evaluation Intake Form 1. Patient Contact Information Patient Name Preferred Name Last First MI Address Best contact phone number: Email address: Primary Care Physician Tel Fax Pharmacy Phone
TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY
TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient
New Patient Information - Adolescent
Scanned Ages 12-17 Dear Parent: To help your clinician understand and help your child, please answer the questions on this form and bring it with you to your child s first appointment. Please print using
Psychiatric Evaluation Intake Form
Psychiatric Evaluation Intake Form 1. Patient Contact Information Date Patient Name Address Best contact phone number Email address Emergency contact Relationship Phone No Primary Care Physician Tel Fax
AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
Supplement: Tables and Figures
Supplement: Tables and Figures Supplement Table 1. Baseline Characteristics by Study and Efavirenz Assignment Supplement Table 2. Baseline Psychoactive Medications by Efavirenz Assignment* Supplement Table
LifePath Systems Medication and Laboratory Formulary
Building stronger communities, person by person LifePath Systems Medication and Laboratory Formulary Last update: 12/04/2018 1 Table of Contents Introduction/Contact Information 3 PAP Medications Overview
Adult Initial Assessment / Patient Questionnaire Page 1
Page 1 Patient Name: Date: Age: Date of Birth: / / Please read the following questions and answer to the best of your ability by placing a checkmark in the appropriate boxes or filling in the blank as
Mental Health Medications. National Institute of Mental Health. U.S. Department of HealtH and HUman ServiceS National Institutes of Health
Mental Health Medications National Institute of Mental Health U.S. Department of HealtH and HUman ServiceS National Institutes of Health Contents Mental Health Medications...1 What are psychiatric medications?...1
NEW PATIENT INTAKE FORM
NEW PATIENT INTAKE FORM Please fill out the following form to the best of your ability. Some sections may not apply to you. We will discuss your responses in greater detail during your first appointment.
PSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
1911 Keller Andrews Road Sanford, NC
1911 Keller Andrews Road Sanford, NC 27330 919.777.9355 www.wellcenteredcounseling.com Well CENTERED Today's date: Patient Information: Individual Name: Date of Birth: Age: (first) (last) Gender M/F Ethnicity
PSYCHIATRIC HISTORY 6. Are you currently seeing a therapist? (Name & contact phone#)
Cool Springs Psychiatric Group PATIENT HISTORY Patient Name Date of Birth Date form completed: *Please arrive on time and bring this form completed to your appointment to avoid any delay in seeing the
Briefly state the reason for this evaluation: Patient s Name: Sex: Male/Female (circle one) Date of Birth: Age: Patient s Social Security #
Psychiatric Evaluation Form After Hours Psychiatry, PLLC Aaron Alaniz, M.D. 25722 Kingsland Blvd, Suite 202 Katy, TX 77494 T: 281-978-2515 F: 281-978-2895 Briefly state the reason for this evaluation:
Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES
PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14
Butrans (buprenorphine patch) Description. Section: Prescription Drugs Effective Date: October 1, 2017
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Butrans Page: 1 of 9 Last Review Date: September 15, 2017 Butrans (buprenorphine patch) Description
Belbuca (buprenorphine buccal film) Belbuca (buprenorphine buccal film) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Belbuca Page: 1 of 9 Last Review Date: September 15, 2017 Belbuca (buprenorphine buccal film)
OBJECTIVES PSYCHOTROPIC MEDICATIONS WHAT IS PSYCHOTROPIC MEDICATION?
PSYCHOTROPIC MEDICATIONS Sally Davies, Ph.D., HSPP Licensed Psychologist OBJECTIVES 1. Identify psychotropic medications and the typical usages 2. Identify effective methods for the practical application
Levorphanol. Levorphanol Tartrate. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.59 Subject: Levorphanol Page: 1 of 8 Last Review Date: March 17, 2017 Levorphanol Description Levorphanol
4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
Levorphanol. Levorphanol Tartrate. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.59 Subject: Levorphanol Page: 1 of 8 Last Review Date: March 16, 2018 Levorphanol Description Levorphanol
Embeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.39 Subject: Embeda Page: 1 of 8 Last Review Date: September 15, 2017 Embeda Description Embeda (morphine
Nucynta IR. Nucynta IR (tapentadol immediate-release) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Nucynta IR Page: 1 of 9 Last Review Date: December 8, 2017 Nucynta IR Description Nucynta IR (tapentadol
South London and the Maudsley NHS Foundation Trust Medicines Formulary
South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1
Welcome and thank you for choosing University of Florida Physicians!
DEPARTMENT OF PSYCHIATRY Tuesday, Division of March Child and 14, Adolescent 2017 Psychiatry 8491 NW 39 th Ave. Gainesville, FL 32606 Phone: 352-265-4357 Fax: 352-627-4163 Welcome and thank you for choosing
Retrospective Drug Use Review for the Use of Psychotropic Medications in Children
Retrospective Drug Use Review for the Use of Psychotropic Medications in Children Recommendations Send providers an annual request for additional clinical data for children receiving any of the following
POSITIVE YOUTH CONCEPTS Child and Adolescent Therapy 24 Front Street, Suite 302 Exeter, NH
Date: / / NEW CLIENT FORM Client s Name: Address: City State Zip D.O.B.: / / Age: Sex: ================================================================================== Guardian s Name: Custody: Physical
90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR
Pre - PA Allowance 12 years of age or older Quantity Immediate-release Formulation Ultracet 720 dosage units per 90 days OR Ultram 720 dosage units per 90 days Extended-release Formulations Ultram ER 90
PROBE INITIAL ZERO/ DK: Please include any prescription medicines, even if you took them only once.
04/18/01 PHARMACOEPIDEMIOLOGY (PH) *PH1. The next questions are about your use of medicines. First, how many different kinds of prescription medicine have you taken during the past seven days? (IF NEC:
Mental Health Intake Form
Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )
Steps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
Medically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
Professor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065
ARABIIC Professor David Castle Ms. Nga Tran St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065 (03) 9288 4147 (03) 9288 4751 Psychiatric Medication Information / Arabic 1 Psychiatric
Hysingla ER. Hysingla ER (hydrocodone bitartrate) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.38 Subject: Hysingla ER Page: 1 of 9 Last Review Date: September 15, 2017 Hysingla ER Description
Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE
Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Drug List Changes - UPDATE Note: This article was previously published in the December 2014 Medicaid
Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Meperidine Page: 1 of 7 Last Review Date: September 15, 2017 Meperidine Description Demerol (meperidine
Belbuca (buprenorphine buccal film) Description. Section: Prescription Drugs Effective Date: October 1, 2016
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Belbuca Page: 1 of 9 Last Review Date: September 15, 2016 Belbuca (buprenorphine buccal film)
CHILD/ADOLESCENT INTAKE FORM
CHILD/ADOLESCENT INTAKE FORM Today's date: 703-437-6311 www.centerforlifestrategies.com Patient Information: Individual Name: Date of Birth: Age: (fi rst) ( la st) Gender M/F Ethnicity (optional): Name
Duragesic patch. Duragesic patch (fentanyl patch) Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.31 Subject: Duragesic patch Page: 1 of 9 Last Review Date: September 15, 2017 Duragesic patch Description Duragesic patch (fentanyl
Psychiatric Distress in Chronic & Terminal Illness Barb Henry, ARNP, MSN
Psychiatric Distress in Chronic & Terminal Illness Barb Henry, ARNP, MSN Psycho-Oncology Consultants, LLC & The University of Cincinnati Central Clinic University of Cincinnati Central Clinic www.centralclinic.org
Iowa Medicaid Mental Health Advisory Group Meeting February 13, Tentative Agenda
CHESTER J. CULVER, GOVERNOR PATTY JUDGE, LT. GOVERNOR DEPARTMENT OF HUMAN SERVICES EUGENE I. GESSOW, DIRECTOR Iowa Medicaid Mental Health Advisory Group Meeting February 13, 2009 Location: Iowa Medicaid
Morphine IR Hydromorphone IR Oxymorphone IR. Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone),
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.33 Subject: Morphine IR Drug Class Page: 1 of 11 Last Review Date: December 8, 2017 Morphine IR Hydromorphone
OXYCODONE IR (oxycodone)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Oxycodone hydrochloride, a pure opioid agonist, is used in the treatment of moderate to severe pain (1-2). The precise mechanism of action is unknown; however,
Duragesic patch. Duragesic patch (fentanyl patch) Description
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.31 Section: Prescription Drugs Effective Date: April1, 2017 Subject: Duragesic patch Page: 1 of 10 Last Review Date: March
Mental Health Intake Form
38600 Van Dyke Ave., Suite 200 Sterling Heights, MI 48313 Phone: (586) 933-5395 Fax: (586) 935-0159 Mental Health Intake Form Please complete all information on this form and bring it to the first visit.
Targiniq ER (oxycodone/naloxone extended-release), Troxyca ER (oxycodone /naltrexone extended-release)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.44 Subject: Oxycodone Naloxone Page: 1 of 9 Last Review Date: December 2, 2016 Oxycodone Naloxone
News & Views. Maryland Medicaid Mental Health Formulary Revisions. Responsible use of Intervention and Outcome Codes
Maryland Medicaid Pharmacy Program News & Views June 2009 Maryland Department of Health and Mental Hygiene / Office of Systems, Operations and Pharmacy Maryland Medicaid Mental Health Formulary Revisions
BELBUCA (buprenorphine buccal film)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Belbuca is indicated for the management of chronic pain severe enough to require daily, aroundthe-clock, long-acting opioid treatment for which alternative
Patients considering TMS Therapy
Charles Hayden MD Patients considering TMS Therapy Thank you for your interest in TMS Therapy. Please take time before you meet with Dr Hayden to carefully fill out this form as completely as possible.
Duragesic patch. Duragesic patch (fentanyl patch) Description. Section: Prescription Drugs Effective Date: January 1, 2019
1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Duragesic patch Page: 1 of 9 Last Review Date: November 30, 2018 Duragesic patch Description Duragesic patch (fentanyl
5151 Research Dr NW Huntsville, AL Ph Fax
INITIAL PACKET Thank you for considering an evaluation with Dr. Charles Hayden. In taking this step, I assume that you have one or more concerns that you would like to address and that you have concluded
Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
APPENDIX E COMMONLY PRESCRIBED MEDICATIONS BY CATEGORY BY BRAND (GENERIC)
APPENDIX E COMMONLY PRESCRIBED MEDICATIONS BY CATEGORY BY BRAND (GENERIC) Revised June 2005 Page E-1 Prescribed Medications by Category by Brand This is not an all-inclusive list ANTIPSYCHOTICS ANTIDEPRESSANTS
Child/Adolescent Intake Form
Child/Adolescent Intake Form Today's date: Patient Information: Individual Name: Date of Birth: / / Age: (First) (Last) Gender: Male Female Ethnicity (optional): Name of Person completing this form: Relationship